Company / Current Assets
Mirum Pharmaceuticals, Inc. Current Assets History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$549.7M
FY2025
5-year range
$166.6M / $549.7M
FY2021-FY2025
Trend
+39.9%
vs FY2024
Sector context
#106 of 213
Health Care
What the data says
At $550M, Mirum Pharmaceuticals, Inc.'s current assets ranks #106 of 213 in the Health Care sector. Current Assets has increased for 4 consecutive years, from $167M in FY2021 to $550M in FY2025.
Based on SEC 10-K filings.
$550M in FY2025 with a 5-year CAGR of +18.4%.
Improved from $388M to $550M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +42.4%
- 5-Year CAGR
- +18.4%
- 10-Year CAGR
- -
Sector benchmark
#106 of 213 in Health CareTop 50% of 213This company $549.7M Sector average $2.5B
▼
-78.2% below sector average
Key checks
Key Insights
- Mirum Pharmaceuticals, Inc.'s current assets has grown for 4 consecutive years.
- 5-year CAGR of +18.4%, indicating consistent growth.
- In FY2025, current assets increased 39.9% year-over-year.
- Ranks #106 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -26.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $549.7M | +39.9% |
| FY2024 | $392.8M | +1.4% |
| FY2023 | $387.5M | +103.7% |
| FY2022 | $190.2M | +14.2% |
| FY2021 | $166.6M | -29.5% |
| FY2020 | $236.3M | +98.0% |
| FY2019 | $119.4M | +129.7% |
| FY2018 | $52.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026